Search research articles
Contact Us
Filters
Showing results (221-230 of 338) with videos related to
Page
of 34
Sort By:
Journal of Viral Hepatitis
|
August 7, 2009
Evolution of hepatitis C virus NS5A region in breakthrough patients during pegylated interferon and ribavirin therapy*
H J Yuan, M Jain, K K Snow, et al.
Lancet (London, England)
|
January 31, 2012
ADDITION-Europe and the case for diabetes screening
John S Yudkin, Victor M Montori, Kasia J Lipska, et al.
Annales De L'Institut Pasteur. Immunology
|
January 1, 1987
On the pathogenesis of human type I diabetes: where do we stand?
G F Bottazzo, I Todd, G Schwarz, et al.
Genomics Data
|
March 17, 2016
Transcriptional analysis of antiviral small molecule therapeutics as agonists of the RLR pathway
R R Green, C Wilkins, S Pattabhi, et al.
Public Health Action
|
October 4, 2019
A retrospective study of tuberculosis outcomes in Gulf Province, Papua New Guinea
I Moses, S Main, R J Commons, et al.
Diabetologia
|
May 29, 2002
Diabetes in the parents of children with Type I diabetes
I F Douek, K M Gillespie, P J Bingley, et al.
Journal of the American Chemical Society
|
December 15, 2016
A Janus Chelator Enables Biochemically Responsive MRI Contrast with Exceptional Dynamic Range
Eric M Gale, Chloe M Jones, Ian Ramsay, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada
|
April 25, 2019
Addressing the rising rates of gonorrhea and drug-resistant gonorrhea: There is no time like the present
M Bodie, M Gale-Rowe, S Alexandre, et al.
Behavior Modification
|
October 18, 2019
Treatment Gains from Early and Intensive Behavioral Intervention (EIBI) are Maintained 10 Years Later
Dean P Smith, Diane W Hayward, Catherine M Gale, et al.
Diabetes, Obesity & Metabolism
|
January 14, 2014
How many people inject insulin? UK estimates from 1991 to 2010
S E Holden, E A M Gale, S Jenkins-Jones, et al.
Page
of 34
Search research articles
Search
Showing results (221-230 of 338) with videos related to
Sort By:
Page
of 34
Journal of Viral Hepatitis
|
August 7, 2009
Evolution of hepatitis C virus NS5A region in breakthrough patients during pegylated interferon and ribavirin therapy*
H J Yuan, M Jain, K K Snow, et al.
Lancet (London, England)
|
January 31, 2012
ADDITION-Europe and the case for diabetes screening
John S Yudkin, Victor M Montori, Kasia J Lipska, et al.
Annales De L'Institut Pasteur. Immunology
|
January 1, 1987
On the pathogenesis of human type I diabetes: where do we stand?
G F Bottazzo, I Todd, G Schwarz, et al.
Genomics Data
|
March 17, 2016
Transcriptional analysis of antiviral small molecule therapeutics as agonists of the RLR pathway
R R Green, C Wilkins, S Pattabhi, et al.
Public Health Action
|
October 4, 2019
A retrospective study of tuberculosis outcomes in Gulf Province, Papua New Guinea
I Moses, S Main, R J Commons, et al.
Diabetologia
|
May 29, 2002
Diabetes in the parents of children with Type I diabetes
I F Douek, K M Gillespie, P J Bingley, et al.
Journal of the American Chemical Society
|
December 15, 2016
A Janus Chelator Enables Biochemically Responsive MRI Contrast with Exceptional Dynamic Range
Eric M Gale, Chloe M Jones, Ian Ramsay, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada
|
April 25, 2019
Addressing the rising rates of gonorrhea and drug-resistant gonorrhea: There is no time like the present
M Bodie, M Gale-Rowe, S Alexandre, et al.
Behavior Modification
|
October 18, 2019
Treatment Gains from Early and Intensive Behavioral Intervention (EIBI) are Maintained 10 Years Later
Dean P Smith, Diane W Hayward, Catherine M Gale, et al.
Diabetes, Obesity & Metabolism
|
January 14, 2014
How many people inject insulin? UK estimates from 1991 to 2010
S E Holden, E A M Gale, S Jenkins-Jones, et al.
Page
of 34